LEESBURG, Va. / Oct 12, 2023 / Business Wire / Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that its Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases. The Q Guidance System for both spine and cranial applications will be featured at the North American Spine Society (NASS) annual meeting in Los Angeles, Oct. 18 - 21, booth no. 1701.
“The surgeon feedback on our Q Guidance System with Spine Guidance Software is overwhelmingly positive, and the number of completed surgical cases has exceeded our expectations,” said Keith Evans, vice president and general manager of Stryker’s Enabling Technologies business. "We’ve seen firsthand how it has helped surgeons optimize their workflow and time spent in the OR. It’s also exciting that we could expand our reach by making this technology available for use with pediatric patients aged 13 and older. The Q Guidance System continues our legacy of ingenuity and is currently the center of our enabling technologies ecosystem that we continue to build upon year over year.”
The Q Guidance System with Spine Guidance Software, which launched in 2022, delivers unmatched speed and the flexibility of multiple optical tracking methods, including full-spectrum active/passive hybrid optical tracking, semi-automatic and automatic processing features, gesture recognition, and broad compatibility with various types of image sets.1
"As a diehard freehand pedicle screw inserter, my first case with the Q Guidance System with Spine Guidance Software changed my views on navigation,” said Dr. Peter Newton*, chief of the Division of Orthopedics & Scoliosis and surgeon-in-chief at Rady Children’s Hospital in San Diego, California. “In surgeries like these, I believe perfect screw positioning and maximal screw length are critical, and both were achieved for this patient. The ability to move the tracker and re-register quickly without another CT scan is a spectacular advance in navigation."
About Stryker
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.
More information is available at www.strykeronegiantleap.com.
References:
* Dr. Peter Newton is a paid consultant of Stryker. His statements represent his own opinions based on personal experience and are not necessarily those of Stryker. Individual results may vary.
Last Trade: | US$364.60 |
Daily Change: | 7.46 2.09 |
Daily Volume: | 2,828,489 |
Market Cap: | US$138.990B |
November 19, 2024 November 14, 2024 October 29, 2024 September 20, 2024 September 17, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB